C12N 2770/24131
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2770/24131 (Uses of virus other than therapeutic or vaccine) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 7
- Assignees
- 3
- Inventors
- 29
- Latest grant
- 25 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Method for detecting flavivirus-specific antibodies utilizing flaviviral NS1 polypeptides comprising the wing domain25 Jun 2024US 12,018,053 B2Roche Diagnostics Operations, Inc.
- Composition of subunit dengue vaccine17 Oct 2023US 11,786,587 B2National Cheng Kung University
- Soluble and immunoreactive flaviviral NS1 polypeptides comprising the wing domain3 May 2022US 11,319,351 B2Roche Diagnostics Operations, Inc.
- Soluble and immunoreactive Zika virus NS1 polypeptides comprising the wing domain26 Apr 2022US 11,312,750 B2Roche Diagnostics Operations, Inc.
- Infectious full-length clone of zika virus or variant thereof and use thereof6 Nov 2025US 2025/0340850 A1RpexBio, Inc.
- Soluble and immunoreactive flavivral ns1 polypeptides14 Jul 2022US 2022/0220158 A1Roche Diagnostics Operations, Inc.
- Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells9 Sep 2021US 2021/0277361 A1
- Composition of subunit dengue vaccine24 Dec 2020US 2020/0397884 A1National Cheng Kung University
- Soluble and immunoreactive zika virus ns1 polypeptides13 Feb 2020US 2020/0048312 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents